ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

EXEL Exelixis Inc

21.925
-1.54 (-6.54%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Exelixis Inc EXEL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-1.54 -6.54% 21.925 10:00:00
Open Price Low Price High Price Close Price Previous Close
21.64 20.69 22.24 21.925 23.46
more quote information »

Recent News

Date Time Source Heading
01/5/202406:05BWExelixis Announces First Quarter 2024 Financial Results and..
17/4/202406:05BWExelixis to Release First Quarter 2024 Financial Results on..
28/2/202410:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202410:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202410:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202410:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202410:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202410:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202408:05BWExelixis to Webcast Fireside Chats as Part of Investor..
24/2/202410:33EDGAR2Form 144 - Report of proposed sale of securities
23/2/202409:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202411:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:19EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/2/202408:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/2/202408:28EDGAR2Form 8-K - Current report
07/2/202408:05BWExelixis Announces Fourth Quarter and Fiscal Year 2023..
02/2/202408:05BWExelixis to Webcast Fireside Chats as Part of Investor..
26/1/202400:00BWExelixis Announces Detailed Results of Phase 3 CONTACT-02..
24/1/202408:05BWExelixis to Release Fourth Quarter and Fiscal Year 2023..
23/1/202409:00BWOpdivo® (nivolumab) in Combination with CABOMETYX®..
19/1/202408:05BWEuropean Patent Office Rules in Favor of Exelixis on..
17/1/202412:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202412:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202412:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202412:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202412:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202413:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202413:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202413:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/1/202413:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202401:06EDGAR2Form 8-K - Current report
08/1/202408:00BWExelixis Announces Preliminary Fiscal Year 2023 Financial..
03/1/202408:05BWExelixis to Present at the 42nd Annual J.P. Morgan..
21/12/202308:20EDGAR2Form 8-K - Current report
15/12/202311:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202311:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202308:56EDGAR2Form 144 - Report of proposed sale of securities
14/12/202308:27EDGAR2Form 144 - Report of proposed sale of securities
13/12/202308:26EDGAR2Form 144 - Report of proposed sale of securities
08/12/202308:05BWExelixis 2023 R&D Day: Science & Strategy to be Webcast on..
05/12/202310:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202300:02BWExelixis Announces Initiation of the STELLAR-305 Phase 2/3..
05/12/202300:00BWExelixis and Arcus Biosciences Announce Clinical Trial..
01/12/202308:10EDGAR2Form 144 - Report of proposed sale of securities
30/11/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202308:05BWExelixis to Present at the Piper Sandler 35th Annual..
21/11/202311:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/11/202301:00BWExelixis Announces Encouraging Results from Expansion Cohort..
10/11/202308:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202307:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

Delayed Upgrade Clock